Physicochemical Properties
| Molecular Formula | C42H65F3N14O18S2 |
| Molecular Weight | 1175.17 |
| Related CAS # | Transdermal Peptide Disulfide;888486-23-5 |
| Appearance | White to off-white solid powder |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Cells will upregulate the amount of ATP1B1 to preserve function and structure in the presence of Transdermal Peptide Disulfide due to the particular binding of Transdermal Peptide Disulfide to ATP1B1; thus, the expression of ATP1B1 increases. But with time, some Transdermal Peptide Disulfide molecules would enter cells through endocytosis; as a result, ATP1B1 expression would decline. The way Transdermal Peptide Disulfide and ATP1B1 interact modifies not only the expression of ATP1B1, but also where it is located and ultimately the epidermal layer's structure. Inhibitors or competitors may lessen this interaction, which would decrease the amount of macromolecular medications that are delivered via the skin[1]. |
| References |
[1]. Role of the Na(+)/K(+)-ATPase beta-subunit in peptide-mediated transdermal drug delivery. Mol Pharm. 2015 Apr 6;12(4):1259-67. |
Solubility Data
| Solubility (In Vitro) | H2O :~100 mg/mL (~85.09 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (85.09 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 0.8509 mL | 4.2547 mL | 8.5094 mL | |
| 5 mM | 0.1702 mL | 0.8509 mL | 1.7019 mL | |
| 10 mM | 0.0851 mL | 0.4255 mL | 0.8509 mL |